ask="7.85"
ask_size="100"
average_daily_volume="60227"
bid="N/A"
bid_size="N/A"
book_value="-19.19"
change="-0.08"
change_from_200_day_moving_average="-0.29"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-13.06"
change_From_52_week_low="0.87"
change_in_percent="-1.14%"
close="6.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.11"
high_52_weeks="20.02"
last_trade_date="2/8/2017"
last_trade_price="6.96"
last_trade_size="100"
last_trade_time="3:56pm"
low="6.88"
low_52_weeks="6.09"
market_capitalization="16.96M"
moving_average_200_day="7.25"
moving_average_50_day="7.15"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="7.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.99%"
percent_change_from_50_day_moving_average="-2.64%"
percent_change_from_52_week_high="-65.23%"
percent_change_from_52_week_low="+14.29%"
previous_close="7.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.68"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="1.08"
stock_exchange="NGM"
symbol="KALV"
volume="21857"
weeks_range_52="6.09 - 20.02"
